MED BIOGENE INC Inactive Instrument
Med Biogene Inc Stock Toronto S.E.
Equities
MBI
CA58402B1076
Biotechnology & Medical Research
| Sales 2022 | - | Sales 2023 | - | Capitalization | 130K 178K |
|---|---|---|---|---|---|
| Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | - |
| Net cash position 2022 | 407 556.08 | Net cash position 2023 | 713 974.17 | EV / Sales 2023 | - |
| P/E ratio 2022 |
-4.96
x | P/E ratio 2023 |
-2.24
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.35% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Iain Weir-Jones
CEO | Chief Executive Officer | - | 14-09-04 |
Ibrahim Ghobrial
DFI | Director of Finance/CFO | - | 14-09-04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Toby Weir-Jones
BRD | Director/Board Member | - | 14-09-04 |
Iain Weir-Jones
CEO | Chief Executive Officer | - | 14-09-04 |
David Diebolt
BRD | Director/Board Member | - | 14-09-04 |
Many Bright Ideas Technologies Inc. is a Canada-based company. The Company is focused on commercializing alternative non-medical technologies. It has not generated any revenue.
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -32.63% | 9.2B | |
| -5.66% | 3.12B | |
| -18.33% | 2.05B | |
| -24.39% | 1.59B | |
| +65.65% | 1.44B | |
| +32.83% | 830M | |
| -6.77% | 720M | |
| -29.80% | 507M | |
| +0.40% | 297M |
